Probiotix Health (AQSE:PBX) Debt-to-Equity : 0.00 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health Debt-to-Equity?

Probiotix Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was £0.00 Mil. Probiotix Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was £0.00 Mil. Probiotix Health's Total Stockholders Equity for the quarter that ended in Jun. 2023 was £1.82 Mil. Probiotix Health's debt to equity for the quarter that ended in Jun. 2023 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Probiotix Health's Debt-to-Equity or its related term are showing as below:

During the past 4 years, the highest Debt-to-Equity Ratio of Probiotix Health was -2.17. The lowest was -2.24. And the median was -2.20.

AQSE:PBX's Debt-to-Equity is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.14
* Ranked among companies with meaningful Debt-to-Equity only.

Probiotix Health Debt-to-Equity Historical Data

The historical data trend for Probiotix Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health Debt-to-Equity Chart

Probiotix Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec22

Debt-to-Equity

-2.17

-2.24

Probiotix Health Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Debt-to-Equity	Get a 7-Day Free Trial			-2.24	N/A	-	-	-

Competitive Comparison of Probiotix Health's Debt-to-Equity

For the Biotechnology subindustry, Probiotix Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Probiotix Health's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Probiotix Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Probiotix Health's Debt-to-Equity falls into.

Probiotix Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Probiotix Health's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	1.991
	=	0.00

Probiotix Health's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	1.815
	=	0.00

Probiotix Health (AQSE:PBX) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Probiotix Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Probiotix Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Probiotix Health (AQSE:PBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

X90:Germany

Address

Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB

Website

https://www.probiotixhealth-ir.com

Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines